v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
OPERATING ACTIVITIES    
Net loss $ (1,404,849) $ (1,016,923)
Stock-based compensation-product development costs 62,168 36,145
Stock-based compensation-selling, general and administrative 248,662
Stock-based compensation-professional fees 8,959 15,225
Interest expense on lines of credit 384,922 314,737
Non-cash imputed interest expense 26,138 31,963
Changes in assets and liabilities    
Decrease (increase) in prepaid expenses (10,121) 16,330
Increase in accounts payable and accrued liabilities 192,817 151,345
Increase in interest payable 137,536 132,218
Net cash used in operating activities (353,768) (318,960)
FINANCING ACTIVITIES    
Proceeds from lines of credit 299,695 192,331
Proceeds from promissory notes 199,395
Repayment of lines of credit interest (80,376) (218,398)
Proceeds from sales of shares of common stock 536,832
Net cash provided by financing activities 418,714 510,765
Effect of foreign exchange on cash (931)
Change in cash 64,015 191,805
Cash, beginning of period 115,922 66,190
Cash, end of period $ 179,937 $ 257,995